Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Dexcom (DXCM) over the last 10 years, with Q4 2025 value amounting to $17.7 million.

  • Dexcom's Non Operating Income fell 2098.21% to $17.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $176.6 million, marking a year-over-year increase of 6201.83%. This contributed to the annual value of $176.6 million for FY2025, which is 6201.83% up from last year.
  • As of Q4 2025, Dexcom's Non Operating Income stood at $17.7 million, which was down 2098.21% from $109.8 million recorded in Q3 2025.
  • Dexcom's 5-year Non Operating Income high stood at $109.8 million for Q3 2025, and its period low was -$8.3 million during Q4 2021.
  • In the last 5 years, Dexcom's Non Operating Income had a median value of $19.2 million in 2025 and averaged $19.9 million.
  • In the last 5 years, Dexcom's Non Operating Income crashed by 90000.0% in 2022 and then skyrocketed by 278461.54% in 2023.
  • Over the past 5 years, Dexcom's Non Operating Income (Quarter) stood at -$8.3 million in 2021, then soared by 196.39% to $8.0 million in 2022, then soared by 266.25% to $29.3 million in 2023, then dropped by 23.55% to $22.4 million in 2024, then decreased by 20.98% to $17.7 million in 2025.
  • Its Non Operating Income was $17.7 million in Q4 2025, compared to $109.8 million in Q3 2025 and $28.5 million in Q2 2025.